Dupilumab for atopic dermatitis linked to lower antibody levels after COVID-19 infection
Benjamin Ungar, MD, and Emma Guttman-Yassky, MD, PhD, discuss their study on how dupilumab for atopic dermatitis is linked to lower antibody levels after COVID-19 infection.